Gastro-intestinal function and immune response Digestive System Gastro-intestinal function and immune response
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male 2. Generally healthy 3. Recreational athlete with at least two years of cycling experience of at least twice a week 4. 18-35 years old 5. Meeting criteria of valid max-test 6. Body mass index (BMI) 20-25 kg/m2 7. Veins suitable for blood sampling at inspection
Exclusion criteria
Exclusion criteria: 1. Known symptoms of immune diseases such as diabetes, celiac disease, gastric disease or cystic fibrosis 2. Known symptoms of intestinal diseases such as Crohn’s disease, ulcerosis, irritable bowel syndrome or cystic fibrosis 3. Smoking 4. Use of hard drugs 5. Use of specific medicines: 6. Chronic use of NSAIDs: aspirin, ibuprofen, etc. 7. Drugs for gastric and/or intestinal function 8. Participation in other scientific studies 9. Blood donation during the last six weeks prior to the start of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Intestinal permeability (lactulose/rhamnose ratio) is measured using HPAEC (with pulsed electrochemical detection) at baseline, and each hour after rest and exercise up to 5 hours 2. Plasma levels of glutamine is measured using the UFLC (ultra fast liquid chromatography) at baseline, during (30 min) and after rest and exercise (60, 90, 120, 180, 360 min) up to 24 hours 3. Glutamine-derived amino acids are measured using the UFLC (ultra-fast liquid chromatography) at baseline, during (30 min) and after rest and exercise (60, 90, 120, 180, 360 min) up to 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastro-intestinal integrity and inflammation markers are measured using ELISA at baseline, during (30 min) and after rest and exercise (60, 90, 120, 180, 360 min) up to 24 hours. | — |
Countries
Netherlands